Skip to main content
. 2019 Jul 2;93(1):e77–e87. doi: 10.1212/WNL.0000000000007720

Figure 4. Rate of disease progression (Unified MSA Rating Scale [UMSARS]).

Figure 4

Rate of disease progression as measured using UMSARS in mesenchymal stem cell (MSC)–treated patients vs the matched control group. UMSARS total (A–C), UMSARS I (D–F), and UMSARS II (G–I) shown as mean and SD of change per month comparing low dose and medium dose to controls (left panels), and change over time per participant in the low-dose (middle panels) and medium-dose group (right panels). Low-dose group = light blue, medium-dose group = dark blue, controls = red.